Antipruritic Market

Future Market Insights

Key Insight

The antipruritic market is projected to grow from USD 11.4 billion in 2025 to USD 16.9 billion by 2035, at a CAGR of 4.0%. Corticosteroids will dominate with a 35.4% market share, while atopic dermatitis will lead the disease segment with a 38.7% share.

September 29, 2025

Anurag Sharma

315 Pages

Cite this Report

Antipruritic Market

https://www.futuremarketinsights.com/reports/antipruritic-market

License

Starting at US$ 5000

Buy Now

Summary ToC Competitive Analysis

Key Players

Amgen
Novartis
The Vanguard Group
Sun Pharmaceutical Industries Ltd
Takeda Pharmaceutical Company Limited
Berkshire Hathaway
XBiotech Inc

Methodology

Member of

Greater New York Chamber of Commerce

Recognized by

Awarded by

SILVER STEVIE® WINNER

Asia Pacific Stevie Awards - 2023

BRONZE STEVIE® Award

20th annual IBAs

Quick Contact

Chat on Whatsapp + 44 20 3769 9709 + 1 347 918 3531 Contact By Email

Get Free Sample PDF

Antipruritic Market

Key Players

Similar Industry Reports